院内感染診断の世界市場:市場規模・現状・予測(2019-2025)

QYResearchが発行した調査報告書(QYR9054050)
◆英語タイトル:Global Hospital-acquired Infection Diagnostics Market Size, Status and Forecast 2019-2025
◆商品コード:QYR9054050
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年8月7日(※2024年版があります。お問い合わせください。)
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当資料は、院内感染診断のグローバル市場について調査・分析したレポートで、種類別(機器と試薬、消耗品)、用途別(病院、診療所、外来手術センター(ASC)、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・院内感染診断の世界市場規模
・主要企業別市場シェア
・院内感染診断の世界市場規模:種類別(機器と試薬、消耗品)
・院内感染診断の世界市場規模:用途別(病院、診療所、外来手術センター(ASC)、その他)
・院内感染診断のアメリカ市場規模(種類別、用途別)
・院内感染診断のヨーロッパ市場規模(種類別、用途別)
・院内感染診断の中国市場規模(種類別、用途別)
・院内感染診断の日本市場規模(種類別、用途別)
・院内感染診断の東南アジア市場規模(種類別、用途別)
・院内感染診断のインド市場規模(種類別、用途別)
・院内感染診断の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・院内感染診断の世界市場予測(2019年-2025年)
・院内感染診断の地域別市場予測(2019年-2025年)
...
【レポートの概要】

In 2018, the global Hospital-acquired Infection Diagnostics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Hospital-acquired Infection Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hospital-acquired Infection Diagnostics development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Advan DX
Alere Inc.
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.

Market segment by Type, the product can be split into
Instrument and Reagents
Consumables

Market segment by Application, split into
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hospital-acquired Infection Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Hospital-acquired Infection Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hospital-acquired Infection Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Instrument and Reagents
1.4.3 Consumables
1.5 Market by Application
1.5.1 Global Hospital-acquired Infection Diagnostics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Ambulatory Surgery Centers (ASC)
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hospital-acquired Infection Diagnostics Market Size
2.2 Hospital-acquired Infection Diagnostics Growth Trends by Regions
2.2.1 Hospital-acquired Infection Diagnostics Market Size by Regions (2014-2025)
2.2.2 Hospital-acquired Infection Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hospital-acquired Infection Diagnostics Market Size by Manufacturers
3.1.1 Global Hospital-acquired Infection Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Hospital-acquired Infection Diagnostics Key Players Head office and Area Served
3.3 Key Players Hospital-acquired Infection Diagnostics Product/Solution/Service
3.4 Date of Enter into Hospital-acquired Infection Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hospital-acquired Infection Diagnostics Market Size by Type (2014-2019)
4.2 Global Hospital-acquired Infection Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States Hospital-acquired Infection Diagnostics Market Size (2014-2019)
5.2 Hospital-acquired Infection Diagnostics Key Players in United States
5.3 United States Hospital-acquired Infection Diagnostics Market Size by Type
5.4 United States Hospital-acquired Infection Diagnostics Market Size by Application

6 Europe
6.1 Europe Hospital-acquired Infection Diagnostics Market Size (2014-2019)
6.2 Hospital-acquired Infection Diagnostics Key Players in Europe
6.3 Europe Hospital-acquired Infection Diagnostics Market Size by Type
6.4 Europe Hospital-acquired Infection Diagnostics Market Size by Application

7 China
7.1 China Hospital-acquired Infection Diagnostics Market Size (2014-2019)
7.2 Hospital-acquired Infection Diagnostics Key Players in China
7.3 China Hospital-acquired Infection Diagnostics Market Size by Type
7.4 China Hospital-acquired Infection Diagnostics Market Size by Application

8 Japan
8.1 Japan Hospital-acquired Infection Diagnostics Market Size (2014-2019)
8.2 Hospital-acquired Infection Diagnostics Key Players in Japan
8.3 Japan Hospital-acquired Infection Diagnostics Market Size by Type
8.4 Japan Hospital-acquired Infection Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hospital-acquired Infection Diagnostics Market Size (2014-2019)
9.2 Hospital-acquired Infection Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Type
9.4 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Application

10 India
10.1 India Hospital-acquired Infection Diagnostics Market Size (2014-2019)
10.2 Hospital-acquired Infection Diagnostics Key Players in India
10.3 India Hospital-acquired Infection Diagnostics Market Size by Type
10.4 India Hospital-acquired Infection Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America Hospital-acquired Infection Diagnostics Market Size (2014-2019)
11.2 Hospital-acquired Infection Diagnostics Key Players in Central & South America
11.3 Central & South America Hospital-acquired Infection Diagnostics Market Size by Type
11.4 Central & South America Hospital-acquired Infection Diagnostics Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hospital-acquired Infection Diagnostics Introduction
12.1.4 Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Advan DX
12.2.1 Advan DX Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hospital-acquired Infection Diagnostics Introduction
12.2.4 Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.2.5 Advan DX Recent Development
12.3 Alere Inc.
12.3.1 Alere Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hospital-acquired Infection Diagnostics Introduction
12.3.4 Alere Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.3.5 Alere Inc. Recent Development
12.4 Astrazeneca PLC
12.4.1 Astrazeneca PLC Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hospital-acquired Infection Diagnostics Introduction
12.4.4 Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.4.5 Astrazeneca PLC Recent Development
12.5 Bayer Schering Pharma LLC
12.5.1 Bayer Schering Pharma LLC Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hospital-acquired Infection Diagnostics Introduction
12.5.4 Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.5.5 Bayer Schering Pharma LLC Recent Development
12.6 Becton Dickinson And Company
12.6.1 Becton Dickinson And Company Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hospital-acquired Infection Diagnostics Introduction
12.6.4 Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.6.5 Becton Dickinson And Company Recent Development
12.7 Cepheid Inc.
12.7.1 Cepheid Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hospital-acquired Infection Diagnostics Introduction
12.7.4 Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.7.5 Cepheid Inc. Recent Development
12.8 Roche AG
12.8.1 Roche AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hospital-acquired Infection Diagnostics Introduction
12.8.4 Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.8.5 Roche AG Recent Development
12.9 Daiichi Sankyo
12.9.1 Daiichi Sankyo Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hospital-acquired Infection Diagnostics Introduction
12.9.4 Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.9.5 Daiichi Sankyo Recent Development
12.10 Hologic, Inc.
12.10.1 Hologic, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hospital-acquired Infection Diagnostics Introduction
12.10.4 Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.10.5 Hologic, Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 院内感染診断の世界市場:市場規模・現状・予測(2019-2025)(Global Hospital-acquired Infection Diagnostics Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。